Skip to main content
OpenTrials

Clinical trial condition

Sexually Transmitted Diseases

Explore clinical trials studying Sexually Transmitted Diseases. Study availability and eligibility vary by location and protocol.

6,133 public trials 372 recruiting studies
Refine in advanced search Browse all conditions

Sexually Transmitted Diseases trial results

Completed

Engagement to Care South Africa

NCT02417233

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +13 more
Locations
  • Moses Kotane Sub-district clinics Mabeskraal, Northwest, South Africa
  • Rustenburg Sub-district clinics Rustenburg, Northwest, South Africa
View Trial Details
Completed

Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

NCT01721109

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • East Bay AIDS Center Medical Group Oakland, California, United States
  • University of South Florida - Department of Pediatrics Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • New York University School of Medicine New York, United States
View all 18 locations
View Trial Details
Completed

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

NCT00578227

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Surrey, British Columbia, Canada
  • GSK Investigational Site Brampton, Ontario, Canada
  • GSK Investigational Site Greater Sudbury, Ontario, Canada
  • GSK Investigational Site Newmarket, Ontario, Canada
View all 21 locations
View Trial Details
Completed

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

NCT00652938

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Nijmegen, Netherlands
  • GSK Investigational Site Rotterdam, Netherlands
  • GSK Investigational Site Linköping, Sweden
  • GSK Investigational Site Luleå, Sweden
View Trial Details
Completed

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

NCT00541970

Conditions
Communicable Diseases, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • GSK Investigational Site Edmonton, Alberta, Canada
  • GSK Investigational Site Langley, British Columbia, Canada
  • GSK Investigational Site St. John's, Newfoundland and Labrador, Canada
  • GSK Investigational Site Truro, Nova Scotia, Canada
View all 25 locations
View Trial Details

Related conditions